Literature DB >> 27956445

Update in diagnosis and management of interstitial lung disease.

Theresia A Mikolasch1, Helen S Garthwaite1, Joanna C Porter2.   

Abstract

The field of interstitial lung disease (ILD) has undergone significant evolution in recent years, with an increasing incidence and more complex, ever expanding disease classification. In their most severe forms, these diseases lead to progressive loss of lung function, respiratory failure and eventually death. Despite notable advances, progress has been challenged by a poor understanding of pathological mechanisms and patient heterogeneity, including variable progression. The diagnostic pathway is thus being continually refined, with the introduction of tools such as transbronchial cryo lung biopsy and a move towards genetically aided, precision medicine. In this review, we focus on how to approach a patient with ILD and the diagnostic process. © Royal College of Physicians 2016. All rights reserved.

Entities:  

Keywords:  Cryoscopic lung biopsy; idiopathic pulmonary fibrosis; interstitial lung disease

Mesh:

Year:  2016        PMID: 27956445      PMCID: PMC6329571          DOI: 10.7861/clinmedicine.16-6-s71

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  8 in total

Review 1.  Clinical mimics: an emergency medicine focused review of pneumonia mimics.

Authors:  Drew Alan Long; Brit Long; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-03-26       Impact factor: 3.397

2.  Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis.

Authors:  Xiang Tong; Yao Ma; Tao Liu; Zhenzhen Li; Sitong Liu; Guihui Wu; Hong Fan
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

3.  Clinical and pathological characteristics of IgG4-related interstitial lung disease.

Authors:  Xiaoting Lv; Feng Gao; Qicai Liu; Sheng Zhang; Zhihua Huang; Yongping Zhu; Haiyang Zong; Quwen Li; Sanyan Li
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

Review 4.  Metabolic Disorders in Chronic Lung Diseases.

Authors:  Ourania Papaioannou; Theodoros Karampitsakos; Ilianna Barbayianni; Serafeim Chrysikos; Nikos Xylourgidis; Vasilis Tzilas; Demosthenes Bouros; Vasilis Aidinis; Argyrios Tzouvelekis
Journal:  Front Med (Lausanne)       Date:  2018-01-18

5.  First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting.

Authors:  Angelo Canora; Carmine Nicoletta; Giacomo Ghinassi; Dario Bruzzese; Gaetano Rea; Annalisa Capaccio; Sabrina Castaldo; Antonietta Coppola; Giorgio Emanuele Polistina; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  Int J Environ Res Public Health       Date:  2019-11-26       Impact factor: 3.390

6.  Transbronchial cryobiopsy for diagnosing parenchymal lung diseases: real-life experience from a tertiary referral center.

Authors:  Demet Turan; Efsun Gonca Uğur Chousein; Aysu Sinem Koç; Mustafa Çörtük; Zeynep Yıldırım; Bariş Demirkol; Mehmet Akif Özgül; Halit Çınarka; Neslihan Akalın; Aytül Hande Yardımcı; Erdoğan Çetinkaya
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-03-31       Impact factor: 0.670

7.  Comparative analysis of the bronchoalveolar microbiome in Portuguese patients with different chronic lung disorders.

Authors:  Susana Seixas; Allison R Kolbe; Sílvia Gomes; Maria Sucena; Catarina Sousa; Luís Vaz Rodrigues; Gilberto Teixeira; Paula Pinto; Tiago Tavares de Abreu; Cristina Bárbara; Júlio Semedo; Leonor Mota; Ana Sofia Carvalho; Rune Matthiesen; Patrícia Isabel Marques; Marcos Pérez-Losada
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

8.  Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung Diseases.

Authors:  Agostino Buonauro; Ciro Santoro; Maurizio Galderisi; Angelo Canora; Regina Sorrentino; Roberta Esposito; Maria Lembo; Mario Enrico Canonico; Federica Ilardi; Valeria Fazio; Bruno Golia; Alessandro Sanduzzi; Marialuisa Bocchino
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.